AllPennyStocks.com SLS, IBRX Stocks Post August Gains: Eli Lilly’s Latest $2.9B Deal Has Retail Traders Bracing For An ‘M&A Rampage’
This section contains press releases and other materials from third parties (including paid content). AllPennyStocks.com has not reviewed this content. Please see our disclaimer.

SLS, IBRX Stocks Post August Gains: Eli Lilly’s Latest $2.9B Deal Has Retail Traders Bracing For An ‘M&A Rampage’

Retail traders viewed the Merida acquisition as evidence that Big Pharma will pay rich premiums for immune-focused platforms.

Other Penny Stock Movers

Nasdaq Biotech Surges 46% on Photonic Supercomputing Acquisition
The First Ounces Out of a New Mine Are Almost Always Spoken For
Copper's Real Constraint Isn't Demand. It's Ground
Most Popular
{{ index + 1 }}
AllPennyStocks.com Favorites


Back to Top